Rising Cases of Appendix Cancer Among Younger Generations

Recent studies indicate that appendix cancer is becoming more common among millennials and Generation X. For individuals born between 1976 and 1984, rates of appendix cancer diagnosis in the U.S. have tripled, particularly for those born from 1981 to 1989.

This research was published on Monday in the Internal Medicine Chronicles. Scientists at Vanderbilt University Medical Center reviewed data from the National Cancer Institute’s Surveillance, Epidemiology and Final Results (SEER) program to arrive at these conclusions.

One noteworthy detail is that one in three patients diagnosed with appendix cancer is under 50 years old. This highlights the urgency of recognizing the signs and symptoms, especially given the rising rates across generations.

According to the National Cancer Institute, appendix cancer is relatively rare, impacting about 1 in every 200 people annually in the U.S. However, medical professionals stress the importance of consulting a doctor if any potential symptoms arise.

“It’s vital to either rule out appendix cancer or catch it early,” said Holowatyj, emphasizing the need to understand the factors contributing to this troubling trend.

Appendix cancer originates in the appendix, a small organ located in the lower right abdomen. There are mainly two types: epithelial cancers, which affect the cells in the inner layer of the appendix, and neuroendocrine cancers caused by the growth of neuroendocrine tumors.

In the disease’s early stages, many people might not realize they have symptoms. As the cancer develops, common signs can include pain, a noticeable mass in the abdomen, nausea, vomiting, and bloating.

Treatment typically involves surgery to remove the appendix and any affected organs, along with chemotherapy aimed at destroying metastatic cancer cells.

Given these findings, researchers are keen to enhance awareness in both public and medical circles. “The increasing incidence in younger populations suggests a future health burden, highlighting the need for more focused research on appendix adenocarcinoma and greater education among healthcare professionals and the general public,” the study asserts.

At present, there are no established screening protocols or known risk factors for appendix cancer. The 5-year survival rate for this type of cancer varies significantly, ranging from 10% to 63%.

The study was funded by the Appendix Cancer Pseudocytoma Research Foundation and the National Institutes of Health.